Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 08 2021
Historique:
entrez: 24 8 2021
pubmed: 25 8 2021
medline: 11 1 2022
Statut: epublish

Résumé

Racial and ethnic minority groups, such as Black, Hispanic, American Indian or Alaska Native, and Asian or Pacific Islander persons, often experience higher rates of severe influenza disease. To describe rates of influenza-associated hospitalization, intensive care unit (ICU) admission, and in-hospital death by race and ethnicity over 10 influenza seasons. This cross-sectional study used data from the Influenza-Associated Hospitalization Surveillance Network (FluSurv-NET), which conducts population-based surveillance for laboratory-confirmed influenza-associated hospitalizations in selected counties, representing approximately 9% of the US population. Influenza hospitalizations from the 2009 to 2010 season to the 2018 to 2019 season were analyzed. Data were analyzed from October 2020 to July 2021. The main outcomes were age-adjusted and age-stratified rates of influenza-associated hospitalization, ICU admission, and in-hospital death by race and ethnicity overall and by influenza season. Among 113 352 persons with an influenza-associated hospitalization (34 436 persons [32.0%] aged ≥75 years; 61 009 [53.8%] women), 70 225 persons (62.3%) were non-Hispanic White (White), 24 850 persons (21.6%) were non-Hispanic Black (Black), 11 903 persons (10.3%) were Hispanic, 5517 persons (5.1%) were non-Hispanic Asian or Pacific Islander, and 857 persons (0.7%) were non-Hispanic American Indian or Alaska Native. Among persons aged younger than 75 years and compared with White persons of the same ages, Black persons were more likely to be hospitalized (eg, age 50-64 years: rate ratio [RR], 2.50 95% CI, 2.43-2.57) and to be admitted to an ICU (eg, age 50-64 years: RR, 2.09; 95% CI, 1.96-2.23). Among persons aged younger than 50 years and compared with White persons of the same ages, American Indian or Alaska Native persons were more likely to be hospitalized (eg, age 18-49 years: RR, 1.72; 95% CI, 1.51-1.96) and to be admitted to an ICU (eg, age 18-49 years: RR, 1.84; 95% CI, 1.40-2.42). Among children aged 4 years or younger and compared with White children, hospitalization rates were higher in Black children (RR, 2.21; 95% CI, 2.10-2.33), Hispanic children (RR, 1.87; 95% CI, 1.77-1.97), American Indian or Alaska Native children (RR, 3.00; 95% CI, 2.55-3.53), and Asian or Pacific Islander children (RR, 1.26; 95% CI, 1.16-1.38), as were rates of ICU admission (Black children: RR, 2.74; 95% CI, 2.43-3.09; Hispanic children: RR, 1.96; 95% CI, 1.73-2.23; American Indian and Alaska Native children: RR, 3.51; 95% CI, 2.45-5.05). In this age group and compared with White children, in-hospital death rates were higher among Hispanic children (RR, 2.98; 95% CI, 1.23-7.19), Black children (RR, 3.39; 95% CI, 1.40-8.18), and Asian or Pacific Islander children (RR, 4.35; 95% CI, 1.55-12.22). Few differences were observed in rates of severe influenza-associated outcomes by race and ethnicity among adults aged 75 years or older. For example, in this age group, compared with White adults, hospitalization rates were slightly higher only among Black adults (RR, 1.05; 95% CI 1.02-1.09). Overall, Black persons had the highest age-adjusted hospitalization rate (68.8 [95% CI, 68.0-69.7] hospitalizations per 100 000 population) and ICU admission rate (11.6 [95% CI, 11.2-11.9] admissions per 100 000 population). This cross-sectional study found racial and ethnic disparities in rates of severe influenza-associated disease. These data identified subgroups for whom improvements in influenza prevention efforts could be targeted.

Identifiants

pubmed: 34427679
pii: 2783448
doi: 10.1001/jamanetworkopen.2021.21880
pmc: PMC8385599
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2121880

Références

Pediatrics. 2016 Mar;137(3):e20153280
pubmed: 26908692
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1122-1126
pubmed: 32817602
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):790-794
pubmed: 32584797
Am J Infect Control. 2014 Jul;42(7):763-9
pubmed: 24799120
Emerg Infect Dis. 2015 Sep;21(9):1543-50
pubmed: 26291121
MMWR Morb Mortal Wkly Rep. 2016 Feb 12;65(5):101-5
pubmed: 26866729
MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1341-4
pubmed: 20010508
PLoS One. 2015 Mar 04;10(3):e0118369
pubmed: 25738736
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):545-550
pubmed: 32379729
Health Aff (Millwood). 2020 Sep;39(9):1624-1632
pubmed: 32663045
Influenza Other Respir Viruses. 2017 Nov;11(6):479-488
pubmed: 28872776
Clin Infect Dis. 2021 Jun 1;72(11):e695-e703
pubmed: 32945846
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Biodemography Soc Biol. 2017;63(3):189-205
pubmed: 29035105
Lancet Glob Health. 2016 Oct;4(10):e726-35
pubmed: 27569362
Am J Public Health. 2014 Jun;104 Suppl 3:S460-9
pubmed: 24754620
Natl Vital Stat Rep. 2020 Jul;69(7):1-18
pubmed: 32730740
MMWR Recomm Rep. 2020 Aug 21;69(8):1-24
pubmed: 32820746
J Gen Intern Med. 2021 May 18;:
pubmed: 34003427
Emerg Infect Dis. 2008 May;14(5):709-15
pubmed: 18439350
Ann Epidemiol. 2011 Aug;21(8):623-30
pubmed: 21737049
Vaccine. 2015 Nov 27;33 Suppl 4:D83-91
pubmed: 26615174
JAMA Netw Open. 2020 Sep 1;3(9):e2021892
pubmed: 32975575
MMWR Surveill Summ. 2017 May 05;66(11):1-28
pubmed: 28472027
Am J Epidemiol. 2013 Apr 1;177(7):656-65
pubmed: 23436899
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1522-1527
pubmed: 33090978
Am J Public Health. 2011 Feb;101(2):285-93
pubmed: 21164098
Ann Intern Med. 2020 Oct 20;173(8):605-613
pubmed: 32833488
World Med Health Policy. 2020 Aug 05;:
pubmed: 32837779

Auteurs

Alissa C O'Halloran (AC)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Rachel Holstein (R)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Charisse Cummings (C)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abt Associates, Rockville, Maryland.

Pam Daily Kirley (P)

California Emerging Infections Program, Oakland.

Nisha B Alden (NB)

Communicable Disease Branch, Colorado Department of Public Health and Environment, Denver.

Kimberly Yousey-Hindes (K)

Connecticut Emerging Infections Program, Yale School of Public Health, New Haven.

Evan J Anderson (EJ)

Departments of Medicine and Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Emerging Infections Program, Georgia Department of Health, Atlanta.
Veterans Affairs Medical Center, Atlanta, Georgia.

Patricia Ryan (P)

Maryland Department of Health, Baltimore.

Sue Kim (S)

Communicable Disease Division, Michigan Department of Health and Human Services, Lansing.

Ruth Lynfield (R)

Minnesota Department of Health, St. Paul.

Chelsea McMullen (C)

New Mexico Department of Health, Santa Fe.

Nancy M Bennett (NM)

University of Rochester School of Medicine and Dentistry, Rochester, New York.

Nancy Spina (N)

New York State Department of Health, Albany.

Laurie M Billing (LM)

Bureau of Infectious Diseases, Ohio Department of Health, Columbus.

Melissa Sutton (M)

Public Health Division, Oregon Health Authority, Portland.

William Schaffner (W)

Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee.

H Keipp Talbot (HK)

Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee.

Andrea Price (A)

Salt Lake County Health Department, Salt Lake City, Utah.

Alicia M Fry (AM)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Carrie Reed (C)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Shikha Garg (S)

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH